Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ERAS | ERASCA INC | Healthcare | 2,700,000.0 | $49.5M | 1.70% | NEW | — | $18.32 | +4.5% |
| 2 | — | PARABILIS MEDICINES INC | — | 1,465,070.0 | $40.1M | 1.38% | NEW | — | $27.37 | — |
| 3 | LEGN | LEGEND BIOTECH CORP | Healthcare | 1,205,000.0 | $34.8M | 1.20% | NEW | — | $28.88 | -28.4% |
| 4 | UNH | UNITEDHEALTH GROUP INC | Healthcare | 80,000.0 | $33.3M | 1.15% | NEW | — | $415.63 | -3.5% |
| 5 | — | PALISADE BIO INC | — | 13,063,687.0 | $27.3M | 0.94% | NEW | — | $2.09 | — |
| 6 | SUPN | SUPERNUS PHARMACEUTICALS | Healthcare | 520,000.0 | $24.2M | 0.83% | NEW | — | $46.51 | -3.5% |
| 7 | NVCT | NUVECTIS PHARMA INC | Healthcare | 1,000,000.0 | $18.4M | 0.63% | NEW | — | $18.39 | +35.9% |
| 8 | CAPR | CAPRICOR THERAPEUTICS INC | Healthcare | 761,737.0 | $18.3M | 0.63% | NEW | — | $24.08 | -61.1% |
| 9 | PRLD | PRELUDE THERAPEUTICS INC | Healthcare | 3,378,378.0 | $18.0M | 0.62% | NEW | — | $5.33 | +23.1% |
| 10 | — | AVALYN PHARMACEUTICALS INC | — | 419,000.0 | $13.8M | 0.47% | NEW | — | $32.92 | — |
| 11 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 147,000.0 | $13.1M | 0.45% | NEW | — | $88.78 | +5.4% |
| 12 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 128,362.0 | $9.0M | 0.31% | NEW | — | $69.81 | +5.7% |
| 13 | CRY | ARTIVION INC | — | 388,000.0 | $8.7M | 0.30% | NEW | — | $22.47 | -22.0% |
| 14 | BLTE | BELITE BIO INC | Healthcare | 50,524.0 | $7.8M | 0.27% | NEW | — | $153.99 | +1.8% |
| 15 | SLN | SILENCE THERAPEUTICS PLC | Healthcare | 630,000.0 | $6.9M | 0.24% | NEW | — | $10.98 | +23.2% |
| 16 | IMUX | IMMUNIC INC | Healthcare | 450,000.0 | $6.9M | 0.24% | NEW | — | $15.37 | +7.3% |
| 17 | ANL | ADLAI NORTYE LTD | Healthcare | 405,523.0 | $4.7M | 0.16% | NEW | — | $11.50 | +31.0% |
| 18 | ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | 950,000.0 | $4.6M | 0.16% | NEW | — | $4.85 | -19.8% |
| 19 | AVBP | ARRIVENT BIOPHARMA INC | Healthcare | 50,000.0 | $1.7M | 0.06% | NEW | — | $34.74 | -10.4% |
| 20 | — | SOLID BIOSCIENCES INC | — | 150,000.0 | $1.5M | 0.05% | NEW | — | $9.99 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%